XML 58 R47.htm IDEA: XBRL DOCUMENT v3.25.2
SEGMENT INFORMATION - Narrative (Details)
$ in Thousands
6 Months Ended 12 Months Ended
Jun. 30, 2025
USD ($)
segment
Dec. 31, 2024
USD ($)
Concentration Risk And Geographic Information [Line Items]    
Number of operating segments | segment 1  
Accounts receivable, net $ 855,855 $ 660,535 [1]
Sanofi    
Concentration Risk And Geographic Information [Line Items]    
Accounts receivable, net $ 128,400 $ 96,800
Credit Concentration Risk | Accounts Receivable | Customer One    
Concentration Risk And Geographic Information [Line Items]    
Total 19.00% 20.00%
Credit Concentration Risk | Accounts Receivable | Customer Two    
Concentration Risk And Geographic Information [Line Items]    
Total 15.00% 11.00%
Credit Concentration Risk | Accounts Receivable | Customer Three    
Concentration Risk And Geographic Information [Line Items]    
Total 11.00%  
[1]
(1)December 31, 2024 balances were derived from the audited Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024, filed with the SEC on February 24, 2025.